1. University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany;
2. Sana Klinikum, Offenbach, Germany;
3. Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany;
4. National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany;
5. MediOnko-Institut GbR, Berlin, Germany;
6. Rotkreuzklinikum, Frauenklinik, Munich, Germany;
7. Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany;
8. TU Dresden, Dresden, Germany;
9. Helios Klinikum Berlin-Buch, Berlin, Germany;
10. Brustzentrum, Elisabeth Krankenhaus, Kassel, Germany;
11. Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany;
12. Johanniter KH Stendal, Stendal, Germany;
13. Gynecology Practice, Hildesheim, Germany;
14. Haemato-Oncology Medicum, Bremen, Germany;
15. Zentrum für Pathologie, Zytologie und Molekularpathologie, FachArztZentrum Neuss, Neuss, Germany;
16. German Breast Group (GBG), Neu-Isenburg, Germany;
17. Department of Gynecology/Breast Center of the Charité, Berlin, Germany;
18. German Breast Group (GBG) and Centre for Haematology and Oncology Bethanien, Frankfurt, Neu-Isenburg, Germany;